Department of Orthopedics, Juye County People's Hospital, Heze City, Shandong Province, China.
Eur Rev Med Pharmacol Sci. 2020 Jan;24(2):535-548. doi: 10.26355/eurrev_202001_20030.
Growing evidence has shown that long non-coding RNAs (lncRNAs) play some roles in the progression of osteoarthritis. In this study, we investigated the functions and mechanisms of lncRNA NKILA (NKILA) of chondrocytes in human osteoarthritis (OA).
RT-PCR was used to detect the expressions of NKILA and miR-145 in OA tissues. After transfection of NKILA overexpression lentivirus (LV-NKILA) and NKILA downregulation lentivirus (LV-shNKILA) into primary chondrocytes, MTT assay was carried out to measure the cell proliferation of chondrocytes. The expressions of SP1, Bcl-2, Bax, cleaved caspase-3 and NF-κB signaling factors were detected by Western blot. Moreover, luciferase assay was performed to explore the binding site of NKILA and miR-145, miR-145 and SP1. Finally, JSH, a NF-κB signaling inhibitor, was added into chondrocytes transfected with LV-shNKILA or miR-145 mimic to detect that NKILA functions via miR-145/SP1/NF-κB signaling pathway.
We found that NKILA and SP1 were significantly reduced, miR-145 was increased in cartilage tissues of OA patients. After LV-NKILA transfection, the proliferation ability of chondrocytes was improved and cell apoptosis was inhibited; however, the proliferation ability of chondrocytes was repressed, and cell apoptosis was increased in LV-sh NKILA group. MiR-145 was predicted to be a potential target of NKILA and luciferase gene reporter assay confirmed that NKILA could directly bind with miR-145. Furthermore, SP1 was predicted to be a target gene of miR-145 and luciferase gene reporter assay proved that miR-145 could directly bind with SP1. Finally, we added JSH, a NF-κB signaling inhibitor, into chondrocytes with LV-shNKILA or miR-145 mimic. Results showed that the repressed SP1 was reversed after the addition of JSH in both LV-shNKILA and miR-145 mimic group. Further, the repressed proliferation capacities and promoted cell apoptosis were also reversed after the addition of JSH.
According to the results, this study uncovers NKILA is reduced in human osteoarthritic cartilage tissues. Furthermore, we firstly uncover that the reduced NKILA could function as a ceRNA to improve miR-145, which inhibited SP1 expression and regulated NF-κB signaling pathway, thereby promoting tissue inflammation, and inhibiting proliferation and promoting apoptosis of chondrocytes. Thus, it may be used as a promising prognostic marker and a potential target for osteoarthritis.
越来越多的证据表明,长非编码 RNA(lncRNA)在骨关节炎的进展中发挥作用。本研究旨在探讨软骨细胞中 lncRNA NKILA(NKILA)在人骨关节炎(OA)中的功能和机制。
采用 RT-PCR 检测 OA 组织中 NKILA 和 miR-145 的表达。转染 NKILA 过表达慢病毒(LV-NKILA)和 NKILA 下调慢病毒(LV-shNKILA)后,通过 MTT 法检测软骨细胞的增殖能力。Western blot 检测 SP1、Bcl-2、Bax、cleaved caspase-3 和 NF-κB 信号因子的表达。此外,通过荧光素酶报告基因实验探索 NKILA 与 miR-145、miR-145 与 SP1 的结合位点。最后,在转染 LV-shNKILA 或 miR-145 模拟物的软骨细胞中加入 NF-κB 信号抑制剂 JSH,检测 NKILA 是否通过 miR-145/SP1/NF-κB 信号通路发挥作用。
我们发现 OA 患者软骨组织中 NKILA 和 SP1 表达明显降低,miR-145 表达升高。转染 LV-NKILA 后,软骨细胞的增殖能力提高,细胞凋亡受到抑制;然而,LV-shNKILA 组软骨细胞的增殖能力受到抑制,细胞凋亡增加。miR-145 被预测为 NKILA 的一个潜在靶标,荧光素酶基因报告实验证实 NKILA 可以直接与 miR-145 结合。此外,SP1 被预测为 miR-145 的靶基因,荧光素酶基因报告实验证实 miR-145 可以直接与 SP1 结合。最后,我们在转染 LV-shNKILA 或 miR-145 模拟物的软骨细胞中加入 NF-κB 信号抑制剂 JSH。结果表明,在 LV-shNKILA 和 miR-145 模拟物组中加入 JSH 后,被抑制的 SP1 得到逆转。此外,加入 JSH 后,被抑制的增殖能力和促进的细胞凋亡也得到逆转。
根据研究结果,本研究揭示了 NKILA 在人骨关节炎软骨组织中减少。此外,我们首次发现,减少的 NKILA 可以作为 ceRNA 来提高 miR-145 的表达,从而抑制 SP1 的表达并调节 NF-κB 信号通路,从而促进组织炎症,并抑制软骨细胞的增殖和促进细胞凋亡。因此,它可能作为一种有前途的预后标志物和骨关节炎的潜在靶点。